Neural Development
Neural development describes the growth and development of the nervous system starting from embryogenesis and continuing throughout life.
Neural Development Products Targets
- FGFR (5)
- GABAB Receptor (28)
- Others (13)
- Stem Cell Signaling (27)
- Stem Cell Proliferation (25)
- Reprogramming (17)
- Nucleoside Transporter (5)
- Glycine Transporter (6)
- GABA (10)
- Cannabinoid Transporter (10)
- Acetylcholine Transporter (1)
- D4 Receptor (12)
- PORCN (4)
- beta-catenin (13)
- Casein Kinase 1 (7)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- D3 Receptor (12)
- Vesicular Monoamine Transporter (4)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Glutamate Transporter (18)
- Dopamine Transporter (20)
- Tankyrase (5)
- Adrenergic Transporter (23)
- 5-HT Transporter (30)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Stem Cell Differentiation (54)
- Delta opioid receptor (16)
- Adrenergic α2 Receptor (33)
- Adrenergic α1 Receptor (22)
- Adrenergic β3 Receptor (12)
- Adrenergic β2 Receptor (6)
- Adrenergic β1 Receptor (7)
- Hedgehog Signaling (15)
- Cancer Stem Cell (9)
Products for Neural Development - Page 18
- Cat.No. Product Name Information/Activity
-
BCC7399
LP 44
824958-12-5
-
BCC7990
DR 4485 hydrochloride
402942-53-4
-
BCC7101
LY 215840
137328-52-0
-
BCC5937
SB 258719 hydrochloride
1217674-10-6
-
BCC5056
SB269970 HCl
SB269970 hydrochloride (SB-269970A) is a hydrochloride salt form of SB-269970, which is a 5-HT7 receptor antagonist with the pKi of 8.3, exhibits >50-fold selectivity against other receptors.
-
BCC6681
8-Hydroxy-DPAT hydrobromide
76135-31-4
-
BCC6266
LP 20 hydrochloride
1386928-34-2
-
BCC7705
3-Bromocytisine
3-Bromocytisine (3-Br-cytisine) is a potent nACh receptors agonist, with IC50s are 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7-nACh, respectively. 3-Bromocytisine (3-Br-cytisine) shows different effects on high (HS) and low (LS) ACh sensitivity α4β2 nAChRs with EC50s are 8 and 50 nM, respectively.
-
BCC7099
5-Iodo-A-85380 dihydrochloride
1217837-17-6
-
BCC7102
5-Iodo-A-85380, 5-trimethylstannyl N-BOC derivative
213766-21-3
